Related Experiment Video
Updated: Aug 2, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk
Kazuki Iio1, Yoshihiko Morikawa2, Koichi Miyata3
1From the Department of General Pediatrics.
Insights
This study identifies a low-risk subgroup of Kawasaki disease (KD) patients for coronary artery aneurysm (CAA). This finding helps tailor treatment for KD, improving outcomes and reducing unnecessary interventions.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Kawasaki disease (KD) poses a risk for coronary artery aneurysm (CAA), necessitating targeted treatment for high-risk patients.
- Characteristics of low-risk KD patients for CAA are less understood, impacting treatment strategies.
Purpose of the Study:
- To characterize Kawasaki disease patients with a low risk of coronary artery aneurysm development.
- To identify predictors and create a decision tree for stratifying KD patients by CAA risk.
Main Methods:
- Secondary analysis of the Post RAISE prospective cohort study in Japan.
- Multivariable logistic regression identified independent predictors of CAA.
- A decision tree was developed to define a low-CAA-risk KD subpopulation.
Main Results:
- Independent predictors of acute-phase CAA included a baseline maximum Z score >2.5, age <12 months, IVIG nonresponsiveness, low neutrophils, high platelets, and high C-reactive protein.
- The decision tree identified 679 KD patients with a low acute-phase CAA incidence (4.1%) and no medium or large CAAs.
Conclusions:
- A distinct subpopulation of Kawasaki disease patients with a low risk of coronary artery aneurysm was identified.
- This low-risk group represents approximately a quarter of the studied cohort, aiding in personalized treatment approaches.
Introduction:
Kawasaki disease (KD) patients with a high risk of coronary artery aneurysm (CAA) development are well characterized and targeted for intensified primary intravenous immunoglobulin (IVIG) treatment. However, the characteristics of KD patients with a low CAA risk are less well-known.
Methods:
The present study was a secondary analysis of Prospective Observational study on STRAtified treatment with Immunoglobulin plus Steroid Efficacy for Kawasaki disease (Post RAISE), a multicenter, prospective cohort study of KD patients in Japan. The target of the analysis was patients with a Kobayashi score <5 who were predicted to respond to IVIG. The incidence of CAA during the acute phase, the primary outcome, was assessed based on all echocardiographic evaluations performed between week 1 (days 5-9) and month 1 (days 20-50) after the start of primary treatment. Multivariable logistic regression was used to identify the independent risk factors of CAA during the acute phase, based on which a decision tree was created to identify a subpopulation of patients with KD with a low CAA risk.
Results:
Multivariate analysis found that a baseline maximum Z score >2.5, age <12 months at fever onset, nonresponsiveness to IVIG, low neutrophils, high platelets and high C-reactive protein were independent predictors of CAA during the acute phase. The decision tree created by using these risk factors identified 679 KD patients who had a low incidence of CAA during the acute phase (4.1%) and no medium or large CAA.
Conclusions:
The present study identified a KD subpopulation with a low CAA risk comprising around a quarter of the entire Post RAISE cohort.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Aneurysm III: Interprofessional Care